APA (7th ed.) Citation

Zheng, S., Li, G., Shi, J., Liu, X., Li, M., He, Z., . . . Kamei, K. (2023). Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release, 361, 819-846. https://doi.org/10.1016/j.jconrel.2023.08.035

Chicago Style (17th ed.) Citation

Zheng, Shunzhe, Guanting Li, Jianbin Shi, Xinying Liu, Meng Li, Zhonggui He, Chutong Tian, and Ken-ichiro Kamei. "Emerging Platinum(IV) Prodrug Nanotherapeutics: A New Epoch for Platinum-based Cancer Therapy." Journal of Controlled Release 361 (2023): 819-846. https://doi.org/10.1016/j.jconrel.2023.08.035.

MLA (9th ed.) Citation

Zheng, Shunzhe, et al. "Emerging Platinum(IV) Prodrug Nanotherapeutics: A New Epoch for Platinum-based Cancer Therapy." Journal of Controlled Release, vol. 361, 2023, pp. 819-846, https://doi.org/10.1016/j.jconrel.2023.08.035.